Hormone replacement therapy after the menopause has a major impact on bone metabolism (1, 2) , although the exact mechanism is still unknown. Oestrogen and progestogen exhibit very characteristic changes during the menstrual cycle (3) . Whether (9) . Pyri¬ dinoline (Pyr) and deoxypyridinoline (D-Pyr) are two mature cross-linking amino acids that have been identi¬ fied in bone, cartilage and, to a lesser extent, other connective tissues except skin (10, 11) . Both Pyr and DPyr have been found to be excreted non-metabolized by the kidney (12) and to be independent of the diet (13 
